Online ISSN: 2515-8260

To assess the severity of COVID-19 in relation toclinical value of immune inflammatory markers: An observational study

Main Article Content

Dr. Preety Motiyani1 , Dr. RS Meena2 , Dr. Dileep Dandotiya3 , Dr. Mamta Meena4* , Dr. Jitendra Rai5

Abstract

Since December 2019, an novel type of pneumonia emergedin Wuhan,China,and rapidly transmitted to wholeglobe. This pneumonia was verified to be caused by a different strain coronavirus and named as coronavirus disease 2019(COVID-19) bythe World Health Organization (WHO). Based on phylogeny,taxonomy and established practice, this novel coronavirus was designated as severe acute respiratory syndrome coronavirus2 (SARS-COV2)

Article Details